Natural considerations for skin of color

Cutis

Volumn 78, Issue 6 SUPPL., 2006, Pages 2-19

  Baumann, Leslie ^a   Rodriguez, David ^b   Taylor, Susan C ^c,d,f   Wu, Jessica ^e,f,g  

^a UNIVERSITY OF MIAMI   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^d New York Presbyterian Columbia University Medical Center   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f JOHNSON AND JOHNSON   (United States)

^g Dr Jessica Wu Cosmeceuticals ^*

Author keywords

[No Author keywords available]

Indexed keywords

COSMETIC; DERMATOLOGICAL AGENT; MELANIN; SUNSCREEN;

DRUG EFFECT; ETHNIC GROUP; ETHNOLOGY; FUNCTIONS OF THE SKIN AND ITS APPENDAGES; HUMAN; PHYSIOLOGY; REVIEW; SEBUM; SECRETION; SKIN; SKIN DISEASE; SKIN PIGMENTATION; ULTRASTRUCTURE;

COSMETICS; DERMATOLOGIC AGENTS; ETHNIC GROUPS; HUMANS; MELANINS; SEBUM; SKIN; SKIN DISEASES; SKIN PHYSIOLOGY; SKIN PIGMENTATION; SUNSCREENING AGENTS;

EID: 33846199551     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (83)

1. US Census Bureau. Interim projections by age, sex, race, and Hispanic origin, 2004. Available at: http://www.census.gov/ipc/www/userinterimproj/. Accessed September 22, 2004.
2. Taylor SC. Enhancing the care and treatment of skin of color, part 1: the broad scope of pigmentary disorders. Cutis. 2005;76:249-255.
3. Fitzpatrick T. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol. 1988;124:869-871.
4. Taylor SC, Arsonnaud S, Czernielewski J; for the Hyperpigmentation Scale Study Group. The Taylor Hyperpigmentation Scale: a new visual assessment tool for the evaluation of skin color and pigmentation. Cutis. 2005;76:270-274.
5. Baumann L. The Skin Type Solution. New York, NY: Bantam Books; 2006.
6. Szabo G, Gerald A, Pathak M, et al. Racial differences in the fate of melanosomes in human epidermis. Nature. 1969;222:1081-1082.
7. Grimes PE, Hunt SG. Considerations for cosmetic surgery in the black population. Clin Plast Surg. 1993;20:27-34.
8. Kaidbey K, Agin P, Sayre R, et al. Photoprotection by melanin - a comparison of black and Caucasian skin. J Am Acad Dermatol. 1979;1:249-260.
9. Halder RM, Grimes PE, McLaurin CI, et al. Incidence of common dermatoses in a predominantly black dermatologic practice. Cutis. 1983;32:388, 390.
10. Stamatas G, Kollias N. Blood stasis contributions to the perception of skin pigmentation. J Biomed Optics. 2004;9:315-322.
11. Seiberg M, Paine C, Sharlow E, et al. Inhibition of melanosome transfer results in skin lightening. J Invest Dermatol. 2000;115:162-167.
12. Harding C. The stratum corneum: structure and function in health and disease. Dermatol Ther. 2004;17(suppl 1):6-15.
13. Sugino K, Imokawa G, Maibach H. Ethnic difference of stratum corneum lipid in relation to stratum corneum function [abstract]. J Invest Dermatol. 1993;100:597.
14. Grimes P, Edison BL, Green BA, et al. Evaluation of inherent differences between African American and white skin surface properties using subjective and objective measures. Cutis. 2004;73:392-396.
15. Marshall E, Lynch V, Smith H. Variation in the susceptibility of the skin to dichloroethylsulfide. J Pharmacol Exp Ther. 1919;12:291-301.
16. Weigand D, Haygood C, Gaylor J. Cell layers and density of Negro and Caucasian stratum corneum. J Invest Dermatol. 1974;62:563-568.
17. Kaidbey K, Kligman A. A human model of coal tar acne. Arch Dermatol. 1974;109:212-215.
18. Reed J, Ghadially R, Elias P. Effect of race, gender, and skin type on epidermal permeability barrier function [abstract]. J Invest Dermatol. 1994;102:537.
19. Berardesca E, Maibach H. Ethnic skin: overview of structure and function. J Am Acad Dermatol. 2003;48(suppl 6):S139-S142.
20. Taylor SC. Enhancing the care and treatment of skin of color, part 2: understanding skin physiology. Cutis. 2005;76:302-306.
21. Smith G. Ashy skin. Skin of Color Scientific Council; June 27, 2004; Philadelphia, Pa.
22. Corcuff P, Lotte C, Rougier A, et al. Racial differences in corneocytes. a comparison between black, white and Oriental skin. Acta Derm Venereol (Stockh). 1991;71:146-148.
23. Kligman AM, Shelley WB. An investigation of the biology of the human sebaceous gland. J Invest Dermatol. 1958;30:99-125.
24. Pochi P, Strauss J. Sebaceous gland activity in black skin. Dermatol Clin. 1988;6:349-351.
25. Montagna W, Carlisle K. The architecture of black and white facial skin. J Am Acad Dermatol. 1991;24:929-937.
26. Halder R, Bridgeman-Shah S. Skin cancer in African Americans. Cancer. 1995;75:667-673.
27. Vermeer M, Schmieder G, Yoshikawa T, et al. Effects of ultraviolet B light on cutaneous immune responses of humans with deeply pigmented skin. J Invest Dermatol. 1991;97:729-734.
28. Rigel D, Friedman R, Kopf A. The incidence of malignant melanoma in the United States: issues as we approach the 21st century. J Am Acad Dermatol. 1996;34:839-847.
29. Byrd K, Wilson D, Hoyler S, et al. Advanced presentation of melanoma in African Americans. J Am Acad Dermatol. 2004;50:21-24.
30. Elmets C, Singh D, Tubesing K, et al. Cutaneous photoprotection from ultraviolet injury by green tea polyphenols. J Am Acad Dermatol. 2001;44:425-432.
31. Grimes PF. Skin and hair cosmetic issues in women of color. Dermatol Clin. 2000;18:659-665.
32. Grimes P, Stockton T. Pigmentary disorders in blacks. Dermatol Clin. 1988;6:271-281.
33. Morelli JG, Norris DA. Influence of inflammatory mediators and cytokines on human melanocyte function. J Invest Dermatol. 1993;100(suppl 2):S191-S195.
34. Scheinfeld NS. Pseudofolliculitis barbae. Skinmed. 2004;3:165-166.
35. Perry PK, Cook-Bolden FE, Rahman Z, et al. Defining pseudofolliculitis barbae in 2001: a review of the literature and current trends. J Am Acad Dermatol. 2002;46(suppl2):S113-S119.
36. Halas L, Liebel F, Martin K. Clinical evaluation of a formulation containing parthenolide-free feverfew for shaving-induced irritation. Poster presented at: 63rd Annual Meeting of the American Academy of Dermatology; February 18-22, 2005; New Orleans, La. P1015.
37. Rendon M, Ciocca G, Gaviria J. The challenge of diagnosing melasma in Hispanic populations. Poster presented at: 61st Annual Meeting of the American Academy of Dermatology; March 21-26, 2003; San Francisco, Calif.
38. Sanchez M. Cutaneous diseases in Latinos. Dermatol Clin. 2003;21:689-697.
39. Kwon OS, Hwang EJ, Bae JH, et al. Seborrheic keratosis in the Korean males: causative role of sunlight. Photodermatol Photoimmunol Photomed. 2003;19:73-80.
40. Hakozaki T, Minwalla L, Zhuang J, et al. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Br J Dermatol. 2002;147:20-31.
41. Taylor S. Skin of color: biology, structure, function, and implications for dermatologie disease. J Am Acad Dermatol. 2002;46(suppl 2):S41-S62.
42. Kimball A, Bissett D, Robinson L, et al. Topical formulation containing N-acetyl glucosamine and niacinamide reduces the appearance of hyperpigmented spots on human facial skin. Poster presented at: 64th Annual Meeting of the American Academy of Dermatology; March 3-7, 2006; San Francisco, Calif.
43. Yokota T, Nishio H, Kubota Y, et al. The inhibitory effect of glabridin from licorice extracts on melanogenesis and inflammation. Pigment Cell Res. 1998;11:355-361.
44. Balina LM, Graupe K. The treatment of melasma. 20% azelaic acid versus 4% hydroquinone cream. Int J Dermatol. 1991;30:893-895.
45. Piamphongsant T. Treatment of melasma: a review with personal experience. Int J Dermatol. 1998;37:897-903.
46. Abello F, Verallo-Rowell V. A randomized double-blind clinical trial to compare melanin reduction in melasma by 4% melfade vs 4% hydroquinone both with glycolic acid and an SPF 45 sunscreen. In: Verallo-Rowell VM, ed. Skin in the Tropics: Sunscreens and Hyperpigmentations. Pasig City, Philippines: Anvil Publishing, Inc; 2001:291-305.
47. Paine C, Shadow E, Liebel F, et al. An alternative approach to depigmentation by soybean extracts via inhibition of the PAR-2 pathway. J Invest Dermatol. 2001;116:587-595.
48. Liu J-C, Wu J, Payonk G, et al. Clinical evaluation of a total soy formulation in improving appearance of skin tone in phototype VI population. Poster presented at: 61st Annual Meeting of the American Academy of Dermatology; February 22-27, 2002; New Orleans, La.
49. Sah A, Stephens TJ, Kurtz ES. Topical acne treatment improves post-acne post inflammatory hyperpigmentation (PIH) in skin of color. Poster presented at: 63rd Annual Meeting of the American Academy of Dermatology; February 18-22, 2005; New Orleans, La. P159.
50. Seiberg M, Liu J-C, Babiarz L, et al. Soymilk reduces hair growth and hair follicle dimensions. Exp Dermatol. 2001;10:405-413.
51. Verallo-Rowell VM, Verallo V, Graupe K, et al. Double-blind comparison of azelaic acid and hydroquinone in the treatment of melasma. Acta Derm Venereol Suppl (Stockh). 1989;143:58-61.
52. Sarkar R, Bhalla M, Kanwar A. A comparative study of 20% azelaic acid cream monotherapy versus a sequential therapy in the treatment of melasma in dark-skinned patients. Dermatology. 2002;205:249-254.
53. Masuda M, Tejima T, Suzuki T. Skin lighteners: an overview of the skin-lightening market in Japan, including an introduction to two new active ingredients. Cosmet Toiletries. 1996;111:65-77.
54. Hautea S, Verallo-Rowell V. A randomized double-blind clinical trial to compare melanin reduction in melasma by 4% hydroquinone vs 2% kojic acid creams both with 10% glycolic acid. In: Verallo-Rowell VM, ed. Skin in the Tropics: Sunscreens and Hyperpigmentations. Pasig City, Philippines: Anvil Publishing, Inc; 2001:272-282.
55. Miller A. Oat derivatives in bath products. Cosmet Toiletries. 1979;94:72-80.
56. Webster F. Oat utilization: past, present and future. In: Webster FH, ed. Oats: Chemistry and Technology. St. Paul, Minn: American Association of Cereal Chemists, Inc; 1986:153-203.
57. MacArthur-Grant L. Sugars and nonstarchy polysaccharides in oats. In: Webster FH, ed. Oats: Chemistry and Technology. St. Paul, Minn: American Association of Cereal Chemists, Inc; 1986:75-91.
58. Grais M. Role of colloidal oatmeal in dermatologic treatment of the aged. AMA Arch Derm Syphilol. 1953;68:402-407.
59. Zhou MX, Robards K, Glennie-Holmes M, et al. Oat lipids. J Am Oil Chem Soc. 1999;76:159-169.
60. Nebus J, Smith G, Miller D, et al. Alleviating dry, ashen skin in patients with skin of color. Poster presented at: 62nd Annual Meeting of the American Academy of Dermatology; February 6-11, 2004; Washington, DC. P294.
61. Nebus J, Wallo W, Sher D, et al. Clinical improvement in skin tone, texture and radiance with facial moisturizers containing total soy complex. Poster presented at: 64th Annual Meeting of the American Academy of Dermatology; March 3-7, 2006; San Francisco, Calif. P1106.
62. Bergfeld WF, Fowler JF, Baumann LS, et al. The four seasons of skin care: the utility of natural ingredients. Cosmet Dermatol. 2004;17(suppl 4):1-9.
63. Leyden J, Grove G, Barkovic S. A double-blind placebo-controlled evaluation of a stabilized retinol treatment with SPF 15 on photodamaged skin. Poster presented at: 57th Annual Meeting of the American Academy of Dermatology; March 19-24, 1999; New Orleans, La.
64. Jackson E. The science of cosmetics. Am J Contact Derm. 1993;4:108-110.
65. Draelos Z. Is the product designed for sensitive skin? Cosmet Dermatol. August 2002;15:71-72, 74-76, 78.
66. Simion F, Rau A. Sensitive skin: what it is and how to formulate for it. Cosmet Toiletries. 1994;109:43-50.
67. Foy V, Weinkauf R, Whittle E, et al. Ethnic variation in the skin irritation response. Contact Dermatitis. 2001;45:346-349.
68. Stephens T, Oresajo C. Ethnic sensitive skin: a review. Cosmet Toiletries. 1994;109:75-80.
69. Vie K, Cours-Darne S, Vienne MP, et al. Modulating effects of oatmeal extracts in the sodium lauryl sulfate skin irritancy model. Skin Pharmacol Appl Skin Physiol. 2002;15:120-124.
70. Saeed SA, Butt NM, McDonald-Gibson WJ, et al. Inhibitor(s) of prostaglandin biosynthesis in extracts of oats (Avena sativa) seeds. Biochem Soc Trans. 1981;9:444.
71. 2 expression in human keratinocytes: potential in cutaneous inflammatory disorders. Biol Pharm Bull. 2005;28:601-606.
72. Boisnic S, Branchet-Gumila MC, Coutanceau C. Inhibitory effect of oatmeal extract oligomer on vasoactive intestinal peptide-induced inflammation in surviving human skin. Int J Tissue React. 2003;25:41-46.
73. Martin K, Southall M, Lyte P, et al. Parthenolide-free feverfew: an extract with effective anti-irritant activity in vitro. Poster presented at: 63rd Annual Meeting of the American Academy of Dermatology; February 18-22, 2005; New Orleans, La. P1039.
74. Liebel F, Southall M, Oddos T, et al. Topical formulations containing parthenolide-free extract of feverfew is highly effective in clinically reducing erythema induced by irritation or barrier disruption of the skin. Poster presented at: 63rd Annual Meeting of the American Academy of Dermatology; February 18-22, 2005; New Orleans, La. P1047.
75. Nebus J, Warren W, Smith G, et al. Evaluating topical preparations in sensitive skin patients. Poster presented at: 63rd Annual Meeting of the American Academy of Dermatology; February 18-22, 2005; New Orleans, La. P1027.
76. Dieck K, Ceilley R, Immeyer J, et al. Anti-inflammatory properties of licochalcone A from Glycyrrhiza inflata on various human skin cells. Poster presented at: 63rd Annual Meeting of the American Academy of Dermatology; February 18-22, 2005; New Orleans, La.
77. Brown D, Dattner A. Phytotherapeutic approaches to common dermatologie conditions. Arch Dermatol. 1998;134:1401-1404.
78. Albring M, Albrecht H, Alcorn G, et al. The measuring of the antiinflammatory effect of a compound on the skin of volunteers. Methods Find Exp Clin Pharmacol. 1983;5:575-577.
79. Davis RH, Parker WL, Murdoch DP. Aloe vera as a biologically active vehicle for hydrocortisone acetate. J Am Podiatr Med Assoc. 1991;81:1-9.
80. Ortiz BI, Clauson KA. Use of herbs and herbal products by Hispanics in south Florida. J Am Pharm Assoc (Wash DC). 2006;46:161-167.
81. Pierard G, Graf J, Gonzalez J, et al. Effect of soy on hyperpigmentation in Caucasian and Hispanic populations. Poster presented at: 59th Annual Meeting of the American Academy of Dermatology; March 2-7, 2001; Washington, DC.
82. Ni Z, Mu Y, Gulati O. Treatment of melasma with Pycnogenol. Phytother Res. 2002;16:567-571.
83. Flores G, Abreu M, Schwartz I, et al. The importance of language and culture in pediatric care: case studies from the Latino community. J Pediatr. 2000;137:842-848.